Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

Related Keywords

London ,City Of ,United Kingdom ,David Forbes Nixon ,Shelagh Mckinlay ,Jacquelin Forbes Nixon ,Martin Kaiser ,Lily Ramsey ,Institute Of Cancer Research ,University Of Leeds ,Institute For Cancer Research ,Jacquelin Forbes Nixon Research Fellowship ,Team Leader Of The Myeloma Molecular Therapy ,General Hospitals ,Cancer Research ,Myeloma United Kingdom ,Team Leader ,Myeloma Molecular Therapy ,Clinical Oncology ,Jacquelin Forbes Nixon Research ,Myeloma ,One ,Bone Marrow ,Dancer ,Iagnostics ,Enetic ,Research ,